In a longstanding and complicated data-i13n=”elm:context_link;elmt:doNotAffiliate;cpos:1;pos:1″ class=”link ” href=”https://www.engadget.com/apple-infringed-masimo-pulse-oximeter-patent-103726704.html” data-ylk=”slk:legal battle;elm:context_link;elmt:doNotAffiliate;cpos:1;pos:1;itc:0;sec:content-canvas”>legal battle between Apple and Masimo, a recent ruling from a California jury may be the first step towards a certain conclusion. As reported by data-i13n=”elm:context_link;elmt:doNotAffiliate;cpos:2;pos:1″ class=”link ” href=”https://www.reuters.com/business/us-jury-says-apple-must-pay-masimo-634-million-smartwatch-patent-case-2025-11-15/” rel=”nofollow noopener” target=”_blank” data-ylk=”slk:Reuters;elm:context_link;elmt:doNotAffiliate;cpos:2;pos:1;itc:0;sec:content-canvas”>Reuters, a federal jury sided with Masimo, a medical tech company known for its patient monitoring devices, when it said that Apple infringed on the company’s patent for technology that tracks blood-oxygen levels.
The case revolves around whether Apple violated Masimo’s patent related to blood-oxygen sensors, which the jury…
